臨床眼科77巻7号

2023年07月発行

今月の話題

新型コロナウイルス感染症流行下における糖尿病網膜症診療への影響

著者： 廣澤邦彦¹²³ 猪俣武範¹²³⁴⁵

所属機関： ¹順天堂大学医学部眼科学講座 ²順天堂大学大学院医学研究科デジタル医療講座 ³順天堂大学大学院医学研究科遠隔医療・モバイルヘルス研究開発講座 ⁴順天堂大学大学院医学研究科病院管理学講座 ⁵順天堂大学大学院医学研究科AIインキュベーションファーム

ページ範囲：P.826 - P.831

　新型コロナウイルス感染症の感染拡大により，本邦では2020年1月に国内初の感染者が報告され，同年4月には緊急事態宣言が発令された。この緊急事態宣言による糖尿病網膜症の定期受診の中断による症状の悪化が懸念されている。本稿では，新型コロナウイルス感染症感染拡大における糖尿病網膜症診療への影響について述べる。

参考文献

1）Wilder-Smith A, Osman S：Public health emergencies of international concern：a historic overview. J Travel Med 27；taaa227, 2020

2）Furuse Y, Ko YK, Saito M et al：Epidemiology of COVID-19 outbreak in Japan, from January-March 2020. Jpn J Infect Dis 73：391-393, 2020

3）Yoshida S, Okubo R, Katanoda K et al：Impact of state of emergency for coronavirus disease 2019 on hospital visits and disease exacerbation：the Japan COVID-19 and society internet survey. Fam Pract 39：883-890, 2022

4）Ikesu R, Miyawaki A, Sugiyama T et al：Trends in diabetes care during the COVID-19 outbreak in Japan：an observational study. J Gen Intern Med 36：1460-1462, 2021

5）土屋彩子・平野隆雄・若林真澄・他：新型コロナウイルス感染症（COVID-19）の流行が糖尿病網膜症定期診療へ及ぼす影響．日本糖尿病眼学会誌26：106-110，2022

6）Cheung N, Mitchell P, Wong TY：Diabetic retinopathy. Lancet 376：124-136, 2010

7）Cunha-Vaz J, Faria de Abreu JR, Campos AJ：Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 59：649-656, 1975

8）GBD 2019 Blindness and Vision Impairment Collaborators；Vision Loss Expert Group of the Global Burden of Disease Study：Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020：the Right to Sight：an analysis for the Global Burden of Disease Study. Lancet Glob Health 9：e144-e160, 2021

9）Arcadu F, Benmansour F, Maunz A et al：Deep learning algorithm predicts diabetic retinopathy progression in individual patients. NPJ Digit Med 2：92, 2019

10）Nguyen HV, Tan GS, Tapp RJ et al：Cost-effectiveness of a national telemedicine diabetic retinopathy screening program in Singapore. Ophthalmology 123：2571-2580, 2016

11）Avidor D, Loewenstein A, Waisbourd M et al：Cost-effectiveness of diabetic retinopathy screening programs using telemedicine：a systematic review. Cost Eff Resour Alloc 18：16, 2020

12）Wong TY, Sun J, Kawasaki R et al：Guidelines on Diabetic Eye Care：The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings. Ophthalmology 125：1608-1622, 2018

13）Solomon SD, Chew E, Duh EJ et al：Diabetic retinopathy：a position statement by the American Diabetes Association. Diabetes Care 40：412-418, 2017

14）Kashim RM, Newton P, Ojo O：Diabetic retinopathy screening：a systematic review on patients' non-attendance. Int J Environ Res Public Health 15：157, 2018

15）Egunsola O, Dowsett LE, Diaz R et al：Diabetic retinopathy screening：a systematic review of qualitative literature. Can J Diabetes 45：725-733. e12, 2021

16）Dupraz J, Le Pogam MA, Peytremann-Bridevaux I. Early impact of the COVID-19 pandemic on in-person outpatient care utilisation：a rapid review. BMJ Open 12：e056086, 2022

17）Brant AR, Pershing S, Hess O et al：The Impact of COVID-19 on missed ophthalmology clinic visits. Clin Ophthalmol 15：4645-4657, 2021

18）Osaguona VB, Osahon AI, Uhumwangho OM：Impact of COVID-19 on ophthalmic outpatient services in an eye care center in Southern Nigeria. Niger J Clin Pract 24：1338-1342, 2021

19）Al-Dwairi R, Rwashdeh H, Otoom M：The Influence of COVID-19 lockdown in Jordan on patients with diabetic retinopathy：a case-control study. Ther Clin Risk Manag 17：1011-1022, 2021

20）Chatziralli I, Dimitriou E, Kazantzis D et al：Effect of COVID-19-associated lockdown on patients with diabetic retinopathy. Cureus 13：e14831, 2021

21）厚生労働省：電子レセプト請求の電子化普及状況等（平成27年4月診療分）について．https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000099015.html（閲覧日：2023年5月8日）

22）Kumamaru H, Fukuma S, Matsui H et al：Principles for the use of large-scale medical databases to generate real-world evidence. Annals of clinical epidemiology 2：27-32, 2020

23）Fujinaga J, Fukuoka T：A review of research studies using data from the administrative claims databases in Japan. Drugs Real World Outcomes 9：543-550, 2022

24）深澤俊貴・田中佐智子・川上浩司：医療データベースを用いた観察研究の可能性．ファルマシア58：777-781，2022

25）Nagai K, Tanaka T, Kodaira N et al：Data resource profile：JMDC claims database sourced from health insurance societies. J Gen Fam Med 22：118-127, 2021

26）An J, Niu F, Turpcu A et al：Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States. Ophthalmic Epidemiol 25：257-265, 2018

27）Piyasena MMPN, Murthy GVS, Yip JLY et al：Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings. PLoS One 14：e0198979, 2019

28）Lindeke-Myers A, Zhao PYC, Meyer BI et al：Patient perceptions of SARS-CoV-2 exposure risk and association with continuity of ophthalmic care. JAMA Ophthalmol 139：508-515, 2021

29）Tham YC, Husain R, Teo KYC et al：New digital models of care in ophthalmology, during and beyond the COVID-19 pandemic. Br J Ophthalmol 106：452-457, 2022

30）van der Heijden AA, Abramoff MD, Verbraak F et al：Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System. Acta Ophthalmol 96：63-68, 2018